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Abstract
Purpose Although office-based transnasal esophagoscopy has been investigated extensively, a cost analysis is still lacking. 
We performed a cost analysis combined with feasibility study for two diagnostic processes: patients with globus pharyngeus 
and/or dysphagia, and hypopharyngeal carcinoma.
Methods Prospective cohort study.
Results Forty-one procedures were performed, of which 35 were fully completed. The procedure was well tolerated with 
mild complaints such as nasal or pharyngeal pain and burping. Four complications occurred: two minor epistaxis and two 
vasovagal reactions. In patients with globus pharyngeus and/or dysphagia, transnasal esophagoscopy resulted in a cost saving 
of €94.43 (p 0.026) per procedure, compared to our regular diagnostic process. In patients with suspicion of hypopharyngeal 
carcinoma, cost savings were €831.41 (p 0.000) per case.
Conclusions Cost analysis showed that office-based transnasal esophagoscopy can provide significant cost savings for the 
current standard of care. Furthermore, this procedure resulted in good patient acceptability and few complications.
Keywords Transnasal esophagoscopy · Office-based · Topical anesthesia · Head and neck oncology · Cost analysis
Introduction
Inspection of the gastrointestinal tract with a flexible fiber-
optic transoral endoscope became available in the late 1950s 
[1]. Shortly thereafter, Hirschowitz reported on a flexible 
fiberoptic esophagoscope with two working channels, ena-
bling suction or obtaining biopsies [2]. Since the 1980s, 
fiberoptic endoscopy has slowly been replaced by distal chip 
endoscopy. In these endoscopes, a charge-coupled device 
(CCD) chip is located in the tip of the endoscope and images 
are seen on a video screen [3]. Since then, addition of a 
working channel in the digital endoscope and enhancement 
of image quality has transformed the field of diagnostic and 
therapeutic endoscopy. Through this ongoing development, 
endoscopes with smaller diameters became available, and 
thus the first studies were published on transnasal esophago-
scopy (TNE) in the 1990s [4, 5].
Since then, TNE has been extensively reported on, and 
has proved to accurately diagnose esophageal pathology 
[6–16]. Several studies showed better patient acceptability 
and less cardiopulmonary stress (i.e., rise in blood pressure 
and heart rate) during TNE, compared to transoral esophago-
scopy [4, 15, 17–29]. Furthermore, TNE can be used for 
therapeutic office-based procedures under topical anesthesia, 
such as foreign body removal or esophageal balloon dilata-
tion [30].
For otorhinolaryngologists and head and neck surgeons, 
inspection of the esophagus can be useful, in patients suffer-
ing from globus pharyngeus or dysphagia, to directly exclude 
mucosal esophageal pathology. Traditional diagnostics for 
these patients are limited to flexible pharyngolaryngoscopy, 
video fluoroscopy, rigid esophagoscopy under general anes-
thesia, and referral to a gastroenterologist in cases requiring 
flexible esophageal inspection. Furthermore, in the diag-
nostic workup of hypopharyngeal carcinoma, inspection of 
the proximal esophagus is usually performed under general 
anesthesia to determine the distal border of the tumor. With 
the introduction of TNE, examination of the esophagus for 
these indications can be performed in the outpatient clinic 
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under topical anesthesia and additional indications are likely 
to be developed and established in the future [30, 31].
Although TNE has been extensively investigated in the 
last 2 decades, a cost analysis is still awaited [32]. There are 
several articles that reported on cost savings of TNE under 
topical anesthesia, but most were estimated cost savings [11, 
18, 33]. Therefore, the goal of this study was to determine 
the actual cost difference for office-based TNE compared 
to two regular diagnostic processes. In patients with glo-
bus pharyngeus and/or dysphagia, the costs of TNE under 
topical anesthesia were compared with traditional flexible 
laryngoscopy and video fluoroscopy. In patients suspected 
of hypopharyngeal carcinoma, costs of TNE under topical 
anesthesia including taking biopsies were compared to the 
common practice of inspection under general anesthesia 
including biopsies. Furthermore, patient experiences and 
safety were evaluated.
Materials and methods
Patient inclusion
This prospective study was conducted in accordance with 
the guidelines established in the Declaration of Helsinki and 
was approved by the local medical ethical committee of our 
center (2015–2156). We estimated that 35 completed pro-
cedures would be sufficient to perform a cost analysis and 
investigate feasibility of office-based TNE. The first included 
patient category were adult patients with globus pharyn-
geus and/or dysphagia. All patients underwent a complete 
examination, including laryngoscopy, in our hospital or in 
the hospital from which they were referred. This patient cat-
egory usually already underwent regular diagnostics (e.g., 
video fluoroscopy) and therapy (e.g., proton pump inhibitor 
or consultation of a speech language pathologist). Thus, they 
were examined to exclude a laryngopharyngeal or esopha-
geal malignancy as the cause for their complaints. The sec-
ond included patient category were patients with suspicion 
of hypopharyngeal carcinoma. These patients were referred 
from other (i.e., secondary) hospitals, if a suspicious tumor 
was seen during flexible laryngoscopy. Other hospitals refer 
patients immediately to reduce diagnostic delay. These 
patients were examined to identify the tumor, determine 
the distal extension in relation to the esophagus, and obtain 
biopsies under topical anesthesia the same day. Furthermore, 
they also underwent imaging diagnostics according to the 
national guidelines. There were no exclusion criteria.
Setting
This study was conducted in our tertiary referral center. 
Patients indicated for one of the two categories were 
included from January to September 2016. All patients were 
consecutively included, until 35 completed procedures were 
performed. This resulted in 41 attempted procedures.
Costs data extraction
Cost analysis was performed from a clinical diagnostic per-
spective, thus secondary costs (e.g., travel expenses, time 
off from work for patients undergoing the diagnostic process 
and family) and capital expenditure were not accounted for. 
For each of the 35 patients that underwent TNE, costs in 
Euros for all materials and procedures were obtained. All 
used materials, prices and sources are displayed in Table 1. 
Costs for the one-time purchase of a transnasal esophago-
scope, transnasal laryngoscope and video processor, were 
depreciated in 5 years on an average of 50 procedures per-
formed each year. The 35 patients were divided into two 
groups, the first group consisted of patients with globus 
pharyngeus and dysphagia (n = 20), and the second group 
consisted of patients with suspicion of hypopharyngeal car-
cinoma (n = 15).
For these two groups, the same number of consecutive 
patients that underwent the diagnostic process in the months 
before we started with TNE (i.e., the regular diagnostic 
process) were searched in our electronic health record sys-
tem based on their medical record codes. For 20 patients 
with globus pharyngeus or dysphagia, the entire diagnostic 
process was evaluated and all costs were extracted. These 
patients underwent several outpatient clinic visits with 
laryngoscopy (VNL 1070STK, Pentax Medical, Uithoorn, 
The Netherlands), and if indicated video fluoroscopy (i.e., 
barium swallow examination). For the 15 patients with a 
suspicion of hypopharyngeal carcinoma, the diagnostic 
process before TNE was a consultation in the outpatient 
clinic with laryngoscopy, and afterwards an investigation 
(laryngopharyngoscopy and proximal esophagoscopy) under 
general anesthesia with biopsies and daycare admission (no 
overnight stay) to the inpatient ward. The average number 
of procedures per patient category is displayed in Table 2.
TNE procedure
Patients were examined in the outpatient clinic of our 
center. Elaborate patient instructions on topical anes-
thesia administration and the procedure were provided. 
The patient was seated, and topical nasal anesthesia was 
administered by placing 2–3 gauze pledgets soaked in 10% 
lidocaine and 0.1% xylometazoline in each nasal cavity. 
The gauze pledgets were left in place for a minimum of 
10–15 min. Furthermore, laryngopharyngeal anesthesia 
was administered by applying around ten sprays of 10% 
lidocaine, which is lower than the maximum dose of lido-
caine application in the larynx [34]. Also, the tip of the 
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endoscope was lubricated with lidocaine gel. Patients were 
advised not to eat or drink until 1 h after the last laryn-
gopharyngeal anesthesia administration, to avoid aspira-
tion due to a desensitized laryngopharynx.
For TNE, a transnasal esophagoscope was used (EE-
1580K, Pentax Medical, Uithoorn, The Netherlands). This 
endoscope has a 5.1 mm outer diameter with a 2.0 mm 
working channel, allowing suction or insufflation during 
Table 1  Costs for each material per patient category
a Institution’s financial department
b Dutch Health Institute. Guideline for performance of economic evaluations in healthcare. February 29, 2016 version. https ://www.zorgi nstit 
uutne derla nd.nl/over-ons/publi catie s/publi catie /2016/02/29/richt lijn-voor-het-uitvo eren-van-econo misch e-evalu aties -in-de-gezon dheid szorg (in 
Dutch). Accessed February 16, 2018
c Pentax Medical; €24,718.00/5 (years)/50 (patient’s per year)
d Pentax Medical; €23,669.00/5 (years)/50 (patient’s per year)
e Pentax Medical; €21.281.00/5 (years)/50 (patient’s per year)
Parameter TNE (€) Regular diagnostic process for globus 
pharyngeus and/or dysphagia (€)
Regular diagnostic process for 
hypopharyngeal carcinoma (€)
Lidocaine 0.18a
Attachment for spraying 0.82a
Xylometazoline 1.02a
Gauze pledgets (10 units) 0.07a
Biopsy forceps 17.00a
Pathology container 1.29a 1.29a
Single wash of endoscope 24.00a
Video fluoroscopy 281.26a
Consulting pathologist 114.38a 114.38a
Surgery (half hour) 440.00a
1-day ward administration 476.00b
Outpatient clinic visit 91.00b 91.00b 91.00b
Single-use transnasal esophagoscope 98.87c
Single-use video processor 94.68d 94.68d 94.68d
Single-use transnasal laryngoscope 85.12e 85.12e 85.12e
Table 2  Average number of 
products used and procedures 
performed per patient category
G/D globus pharyngeus and/or dysphagia, H hypopharyngeal carcinoma
Parameter TNE (G/D) TNE (H) Regular diagnostic 
process (G/D)
Regular diag-
nostic process 
(H)
Lidocaine 1 1 0 0
Attachment for spraying 1 1 0 0
Xylometazoline 1 1 0 0
Gauze pledgets (10 units) 1 1 0 0
Biopsy forceps 0.35 0.73 0 0
Pathology container 0.35 0.73 0 1
Single wash of endoscope 1 1 0 0
Video fluoroscopy 0 0 0.8 0.07
Consulting pathologist 0.35 0.35 0 1
Surgery (half hour) 0 0 0 1
1-day ward administration 0 0 0 1
Outpatient clinic visit 1 2 2.35 2.05
Transnasal esophagoscopy 1 1 0 0
Transnasal laryngoscopy 1 1 1.55 1.05
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examination. Digital images were processed using a video 
processor (EPK-i5000-HD, Pentax Medical, Uithoorn, The 
Netherlands).
After pharyngolaryngoscopy, the endoscope was directed 
into the pyriform sinus. The patient was asked to swallow, 
after which the endoscope was inserted into the esophagus 
and passed into the stomach. The stomach was inspected, 
including the caudal portion of the distal esophageal sphinc-
ter, by retroflexion of the tip of the endoscope, also known as 
the ‘J-maneuver’. Inspection of the mucosa of the esophagus 
was performed by retracting the endoscope slowly upwards, 
gaining circumferential sight of the esophagus by repeated 
insufflations of air through the working channel of the endo-
scope. In case of suspicious lesions, biopsies were taken 
with a flexible endoscopic biopsy forceps (Radial Jaw™ 4 
pulmonary standard capacity with needle 1.8 mm diameter, 
Boston Scientific, Costa Rica).
After TNE, patients were asked to complete a question-
naire containing five questions regarding their experiences 
during the procedure. A visual analogue scale (VAS) was 
used to rate patients’ experiences concerning nasal pain dur-
ing endoscope insertion, throat pain during examination, and 
inconvenience due to gag reflex, nausea, and burping. Each 
question is rated on a scale from 1 to 10, where 1 is the least 
unpleasant and 10 is the most unpleasant.
Analysis
Statistical analysis was performed using IBM Statisti-
cal Package for Social Sciences Statistics 22 (IBM Corp. 
Released 2013. IBM SPSS Statistics for Windows, Version 
22.0. Armonk, NY: IBM Corp). For cost analysis, the two 
groups were analyzed using independent-sample t test and 
bootstrapping.
Results
Between January 2016 and September 2016, 41 TNE 
procedures under topical anesthesia were attempted. The 
results are summarized in Table 3. Cost analysis for the 
first group (i.e., patients with globus pharyngeus and/or 
dysphagia) revealed a significant cost difference in favor of 
TNE. The mean difference in costs was €94.43 (p 0.026) 
per procedure, with mean costs of €532.80 for TNE and 
€627.23 for the regular diagnostic process. This difference 
remained statistically significant after bootstrapping (p 
0.035). For the second group (i.e., patients with suspicion 
of hypopharyngeal carcinoma), even more extensive differ-
ences were found. The diagnostic process with office-based 
TNE (mean costs €583.54) was significantly less expensive 
(p 0.000) compared to the regular diagnostic process (mean 
costs €1414.95), with a mean cost difference of €831.41 per 
procedure. Again, the difference remained statistically sig-
nificant after bootstrapping (p 0.001).
Thirty-five procedures (85.3%) were completed. Mean 
VAS score for patient experience was 2.2 for burping, 1.9 for 
nasal pain during insertion, 1.7 for throat pain, 1.5 for gag-
ging, and 0.3 for nausea. Six procedures were not completed, 
four (9.8%) due to failure of passage of the esophagoscope 
through the nose, and two (4.9%) due to vasovagal reaction 
of the patient. Both patients experienced light headedness 
and nausea, but did not lose consciousness, and recovered 
without sequelae. Two patients experienced epistaxis after 
TNE, which was resolved after placing cotton pledgets 
soaked in 0.1% xylometazoline in the nasal cavity. After 
a short observation, both patients fully recovered without 
sequelae. Of the 20 patients that underwent TNE for globus 
pharyngeus and/or dysphagia, 4 cases (20%) revealed pri-
mary or residual laryngeal carcinoma and for 4 cases (20%) 
primary esophageal carcinoma.
Discussion
Although office-based TNE has been extensively investi-
gated in the last decades and several studies mentioned the 
estimated cost savings for office-based TNE, a cost analysis 
was never performed [11, 18]. Therefore, we conducted this 
prospective clinical study to analyze the cost savings of TNE 
for two diagnostic indications, and investigate the feasibility 
at our tertiary referral center.
We demonstrated that office-based TNE provides signifi-
cant cost savings in patients suffering from globus pharyn-
geus and/or dysphagia, in whom the primary goal was to 
exclude an esophageal tumor as the cause of their com-
plaints. Even more significant cost reduction was found in 
patients with (suspicion of) hypopharyngeal carcinoma that 
underwent office-based TNE with biopsies. In these patients, 
examination under general anesthesia with biopsies can be 
omitted. As was expected, cost savings were even greater 
compared to cost savings for patients with globus pharyn-
geus and dysphagia.
An overall advantage of TNE is the favorable patient 
acceptance, as our own experience and several other studies 
have shown [30]. Only few minor complications occurred, 
with no long-lasting consequences for the patient. When 
reviewing our complications compared to the literature, we 
noticed higher rates of epistaxis and vasovagal reaction [30]. 
In patients with globus pharyngeus and/or dysphagia, 20% 
of the patients had esophageal carcinoma found during TNE. 
Although this rate was surprisingly high, similar rates have 
been reported in the literature [30]. Patients with globus 
pharyngeus and/or dysphagia that are referred to our ter-
tiary hospital, are probably a selected group of patients and 
different, compared to the category of patients that are seen 
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in a non-academic secondary referral clinic. Most esopha-
geal pathologies were found in patients suffering from both 
globus pharyngeus and dysphagia, thus this combination 
might be a strong indication to perform TNE. An ongo-
ing point of discussion is the screening for second primary 
tumors in the esophagus by esophagoscopy in patients with 
hypopharyngeal carcinoma, given the relatively higher inci-
dence of esophageal carcinoma in these patients [30]. The 
short duration of a TNE, with few complications and good 
patient acceptance, could favor performing TNE, especially 
if the incidence rates of esophageal carcinoma are as high 
as found in our study.
Although we did not investigate this in our current 
study, our experience is that office-based TNE results in 
a faster diagnostic process [35]. In patients with globus 
pharyngeus and/or dysphagia, office-based TNE gives 
Table 3  Patient characteristics
a One patient with globus pharyngeus and dysphagia had residual laryngeal carcinoma and Barrett’s esoph-
agus
b One patient with globus pharyngeus and dysphagia had a tumor in the oral cavity, oropharynx and esopha-
gus
c These were patients with suspected lesions that were seen on PET and/or CT
d One patient with a suspected esophageal tumor on PET showed no pathology in the esophagus, but resid-
ual laryngeal carcinoma
e Visual analogue scale (VAS): 0 = no complaints, 10 = unbearable complaints
Characteristics TNE %
Study population 41 100
Sex (males) 28 68.3
Age (range) 66.6 (29–87)
Indication
 Globus pharyngeus and/or dysphagia 26 63.4
 Suspicion hypopharyngeal/esophageal carcinoma 15 36.6
Completed procedures 35 85.3
Discontinued procedures 6 14.7
 No nasal passage endoscope 4 9.8
 Complication 2 4.9
Duration (range minutes) 15.03 (6.38–35.00)
Clinical findings 35 100
 Globus pharyngeus and/or dysphagia 20 57.1
  No suspicious lesions 11 31.4
  Laryngeal cyst 2 5.7
  Barrett’s  esophagusa 1 2.9
  Laryngeal carcinoma (primary or residual)a,b 4 11.4
  Esophageal  carcinomab 4 11.4
 Suspected hypopharyngeal tumor 10 28.6
  Hypopharyngeal carcinoma 8 22.9
  No suspicious lesions 2 5.7
 Suspected esophageal  tumorc 5 14.3
  Esophageal carcinoma 1 2.9
  No suspicious lesions 4 11.4 (4/35)
  Laryngeal  carcinomad 1 2.9
Complication
 Epistaxis 2 4.9
 Vasovagal reaction 2 4.9
VAS score patient tolerance (average)e
 Burping 2.2
 Pain in nose 1.9
 Pain in throat 1.7
 Gagging 1.5
 Nausea 0.3
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less burden for the patient. When no pathology is found, 
patients can be reassured immediately and secondary 
diagnostics (e.g., video fluoroscopy or referral to a gas-
troenterologist) can be avoided. Furthermore, TNE might 
replace video fluoroscopy, as it is a faster procedure, with 
significant cost savings and no radiation exposure. Due to 
this study, a significant decrease in video fluoroscopy has 
occurred in our center for patients with globus pharyn-
geus and/or dysphagia. If esophageal pathology is encoun-
tered during endoscopy, histology can also be obtained. 
All patients referred to us with suspicion of a head and 
neck malignancy are seen weekly in our multidisciplinary 
head and neck oncological center. With the introduction 
of TNE in the diagnostic process, patients with suspected 
hypopharyngeal carcinoma undergo TNE the same day to 
identify the distal border of the tumor, and biopsies are 
obtained. By arranging a fast diagnostic track, biopsies 
during TNE (instead of endoscopy under general anes-
thesia) are evaluated within 2 days by the pathologist and 
our diagnostic process has shortened from two and a half 
weeks, to 2 days.
Potential limitations of this study are the limited num-
ber of patients included and the lack of a power analysis, 
which could result in less reliable data. We chose the num-
ber of 35 participants in the context of evaluation of fea-
sibility for TNE at our department. We performed a post 
hoc power analysis, that showed high power (1 − β 0.91) 
for the chosen sample size. Furthermore, indirect costs 
(i.e., secondary costs and capital expenditure) were not 
evaluated in this study, because our goal was to evaluate 
the cost savings from a medical perspective. By includ-
ing these costs, such as travel time and time of absence 
from work of patients and their family, a more robust cost 
analysis could be performed.
In conclusion, office-based TNE resulted in significant 
cost savings, for patients with globus pharyngeus and/or 
dysphagia, and suspicion of hypopharyngeal carcinoma. 
Furthermore, this procedure resulted in good patient 
acceptance and had few complications.
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